Patents by Inventor John Schullek

John Schullek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Their Use as Anti-Tumor Agents
    Publication number: 20120071513
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: November 28, 2011
    Publication date: March 22, 2012
    Applicant: COMPASS PHARMACEUTICALS LLC
    Inventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
  • Compositions and Their Use as Anti-Tumor Agents
    Publication number: 20110178087
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: March 30, 2011
    Publication date: July 21, 2011
    Applicant: Compass Pharmaceuticals LLC.
    Inventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
  • Compositions and their use as anti-tumor agents
    Publication number: 20090018145
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreating carcinomas) and mesotheliomas.
    Type: Application
    Filed: October 18, 2005
    Publication date: January 15, 2009
    Applicant: Compass Pharmaceuticals LLC
    Inventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
  • Topoisomerase inhibitors
    Publication number: 20070004701
    Abstract: The present invention provides compounds that are effective against inhibiting topoisomerase (i.e., topoisomerase I and/or topoisomerase II). These compounds are used for treating cell-proliferative disorders. In some instances, these compounds have anticancer activity, e.g., against multi-drug resistant cancers.
    Type: Application
    Filed: May 25, 2005
    Publication date: January 4, 2007
    Applicant: Propharmacon, Inc.
    Inventors: Martin Murphy, John Schullek, John Ward, Gary Look, Brian Siesel
  • N-aryl piperidine compounds
    Publication number: 20060035932
    Abstract: The present invention provides N-aryl piperidine compounds having antiinfective activity (i.e., antibacterial, antiviral), their compositions and methods of use. The compounds of the invention prevent the entry of HIV into host cells. More particularly, the compounds are effective at in inhibiting the binding interaction of HIV glycoprotein gp120 and the cell surface receptor CD4. The compounds can be used alone or in combination with other antivirals, antiinfectives, immunomodulators, or HIV entry inhibitors. More particularly, the invention relates to the prevention and treatment of HIV infectivity and AIDS.
    Type: Application
    Filed: May 25, 2005
    Publication date: February 16, 2006
    Applicant: Propharmacon, Inc.
    Inventors: Martin Murphy, John Schullek, John Ward, Gary Look, Rama Jain, Laurence Lee